A detailed history of Neuberger Berman Group LLC transactions in Geron Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 20,364 shares of GERN stock, worth $87,361. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,364
Holding current value
$87,361
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.1 - $5.09 $63,128 - $103,652
20,364 New
20,364 $86,000
Q1 2023

May 12, 2023

BUY
$2.14 - $3.4 $21,920 - $34,826
10,243 New
10,243 $22,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.62B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.